The mRNA-binding protein IGF2BP1 maintains intestinal barrier function by up-regulating occludin expression
Open Access
- 1 June 2020
- journal article
- research article
- Published by Elsevier BV in Journal of Biological Chemistry
- Vol. 295 (25), 8602-8612
- https://doi.org/10.1074/jbc.ac120.013646
Abstract
No abstract availableKeywords
Funding Information
- HHS | NIH | National Cancer Institute (CA191550)
- HHS | NIH | National Cancer Institute (CA243167)
- HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (DK114024)
This publication has 57 references indexed in Scilit:
- Competitive binding of CUGBP1 and HuR to occludin mRNA controls its translation and modulates epithelial barrier functionMolecular Biology of the Cell, 2013
- Occludin: One Protein, Many FormsMolecular and Cellular Biology, 2012
- The pINDUCER lentiviral toolkit for inducible RNA interference in vitro and in vivoProceedings of the National Academy of Sciences of the United States of America, 2011
- Transcriptome-wide Identification of RNA-Binding Protein and MicroRNA Target Sites by PAR-CLIPCell, 2010
- Caveolin-1–dependent occludin endocytosis is required for TNF-induced tight junction regulation in vivoThe Journal of cell biology, 2010
- Inflammatory Bowel DiseaseThe New England Journal of Medicine, 2009
- CRD-BP Protects the Coding Region of βTrCP1 mRNA from miR-183-Mediated DegradationMolecular Cell, 2009
- Detectable serum flagellin and lipopolysaccharide and upregulated anti-flagellin and lipopolysaccharide immunoglobulins in human short bowel syndromeAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2008
- Chemically induced mouse models of intestinal inflammationNature Protocols, 2007
- CRD-BP shields c-myc and MDR-1 RNA from endonucleolytic attack by a mammalian endoribonucleaseNucleic Acids Research, 2007